OM
Opaleye Management’s Rhythm Pharmaceuticals RYTM Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $30M | Sell |
475,000
-15,000
| -3% | -$948K | 6.07% | 7 |
|
2025
Q1 | $26M | Sell |
490,000
-10,000
| -2% | -$530K | 5.78% | 5 |
|
2024
Q4 | $28M | Hold |
500,000
| – | – | 4.9% | 7 |
|
2024
Q3 | $26.2M | Sell |
500,000
-15,000
| -3% | -$786K | 4.37% | 6 |
|
2024
Q2 | $21.1M | Hold |
515,000
| – | – | 4.83% | 4 |
|
2024
Q1 | $22.3M | Sell |
515,000
-95,000
| -16% | -$4.12M | 4.86% | 5 |
|
2023
Q4 | $28M | Sell |
610,000
-43,000
| -7% | -$1.98M | 7.46% | 4 |
|
2023
Q3 | $15M | Sell |
653,000
-82,000
| -11% | -$1.88M | 4.87% | 5 |
|
2023
Q2 | $12.1M | Hold |
735,000
| – | – | 2.9% | 8 |
|
2023
Q1 | $13.1M | Hold |
735,000
| – | – | 3.93% | 4 |
|
2022
Q4 | $21.4M | Sell |
735,000
-75,000
| -9% | -$2.18M | 7.44% | 3 |
|
2022
Q3 | $19.8M | Buy |
810,000
+448,000
| +124% | +$11M | 8.2% | 3 |
|
2022
Q2 | $1.5M | Buy |
+362,000
| New | +$1.5M | 0.68% | 33 |
|
2021
Q1 | – | Sell |
-115,000
| Closed | -$3.42M | – | 65 |
|
2020
Q4 | $3.42M | Buy |
+115,000
| New | +$3.42M | 0.45% | 45 |
|
2020
Q1 | – | Sell |
-110,500
| Closed | -$2.54M | – | 50 |
|
2019
Q4 | $2.54M | Buy |
+110,500
| New | +$2.54M | 0.5% | 42 |
|
2018
Q1 | – | Sell |
-38,300
| Closed | -$1.11M | – | 44 |
|
2017
Q4 | $1.11M | Buy |
+38,300
| New | +$1.11M | 0.36% | 32 |
|